Isotretinoïne Mylan (Isotretinoin)

Isotretinoin acts by binding to nuclear retinoic acid receptors, which down‑regulates genes involved in sebaceous gland growth and sebum production. It also normalizes follicular keratinization and exerts anti‑inflammatory effects, thereby reducing the formation of comedones, papules, pustules, and cysts associated with severe acne.

The dosage of isotretinoin is individualized by the prescribing clinician based on body weight, severity of acne, and laboratory parameters. The prescriber determines the appropriate daily dose, treatment duration, and any necessary dose adjustments throughout therapy.

Isotretinoïne Mylan is classified as Pregnancy Category X because it is highly teratogenic. It must not be used by pregnant women or women who may become pregnant. Breastfeeding is also contraindicated, as isotretinoin can be excreted in milk and may harm the infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with antibiotics, hormonal agents or topical retinoids, isotretinoin offers a unique disease‑modifying effect by permanently reducing sebaceous gland size and sebum output. While other treatments manage symptoms, isotretinoin can achieve long‑term remission after a finite course, but it requires careful monitoring for systemic side effects.

Isotretinoïne Mylan should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, heat and direct sunlight, and ensure the packaging remains sealed until use.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but a consistent approach (with meals or on an empty stomach) helps maintain stable absorption. Patients should follow the prescriber’s instructions regarding timing and any dietary considerations.

The most serious risks include teratogenicity leading to severe birth defects, significant mood disorders such as depression or suicidal ideation, and rare but severe organ toxicities like pancreatitis, inflammatory bowel disease, and marked hypertriglyceridemia. Prompt medical evaluation is essential if any of these symptoms arise.

Isotretinoïne Mylan is contraindicated in pregnant women, women planning pregnancy, and individuals who cannot ensure effective contraception. It should also be avoided in patients with pre‑existing severe liver disease, uncontrolled hyperlipidemia, or a history of severe depression without close psychiatric supervision.